Vivet Therapeutics SAS

Coave Therapeutics

The company develops targeted gene therapies for patients with neurodegenerative and ocular diseases.

Comet Therapeutics

This biotechnology company develops coenzyme A metabolism therapies to treat patients with inherited metabolic diseases and orphan neurological disorders.

Stridebio

This company develops engineered viral vectors and gene therapies for patients with rare genetic diseases.

Resalis Therapeutics

This company develops non-coding RNA therapies to treat metabolic disorders, including obesity and fatty liver disease, for patients with unmet medical needs.

Axovia Therapeutics

The company develops gene therapies for patients with ciliopathies, specifically targeting rare genetic conditions like Bardet-Biedl Syndrome to treat blindness and obesity.

Genespire

This company develops off-the-shelf gene therapies for children and adults affected by inherited metabolic diseases and primary immunodeficiencies.

Rampart Biosciences

This company develops non-viral, DNA-based gene medicines for patients with serious genetic disorders, specifically focusing on liver-related conditions like hypophosphatasia.

Salve Therapeutics

The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.